headroom on intangible valuations would be surely getting tight on the MSC platform given the inherent potency issue that has seen Rem-L knocked back 2 times now
Cell Therapy News/Articles, page-17032
-
- There are more pages in this discussion • 789 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.005(0.43%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $2.556M | 2.186M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 66095 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 960 | 1 |
View Market Depth
| Last trade - 13.27pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |